Previously, we have demonstrated that NAT10 is downregulated in colorectal cancer samples and that NAT10 inhibits cell proliferation and colony formation in cells expressing wild-type p53, indicating that NAT10 could inhibit tumorigenesis through regulating p53 [26]. The gene discussed is TP53; the disease is colorectal cancer.